|Day Low/High||60.44 / 61.17|
|52 Wk Low/High||42.50 / 63.29|
Wise investors should stick with those equities and stay away from high-yielders with no protection, like the MLPs.
Equity index futures were rising Monday morning on positive trade news.
Southern Company and Consolidated Edison are among the most highly regarded dividend payers in the utility sector.
It's awfully hard to tell what anyone is thinking or what patterns might exist that can be gamed and played.
Each of these stocks pays at least a 4.5% dividend yield.
Consistency in discipline will make the difference.
These names are showing bullish and bearish technical patterns over the past week.
Even in a time of rising rates, utility stocks should have a place in your portfolio.
If you purchased Bitcoin one month ago today, you are now down heavily on your investment.
Firms that adapted to hard times are now doing exponentially better.
A utility play now that Janet Yellen has changed rate-hike expectations.
No doubt about it, three full months into 2017, and this year is shaping up to be a "stock picker's market."
Here's a look at four big stocks that could be about to increase their dividend payments in the coming months.
These popular stocks look ready to increase their dividend payouts to shareholders in the weeks ahead.
U.S. stocks end off their highs to end lower after crude oil tumbles to a one-month low.
Be aware that Johnson & Johnson, American Electric Power and Federal Realty don't roll over idly.
Action Alerts PLUS team lauds company's 'ability to create long-term, sustainable shareholder value.'
First-quarter performance was a mixed bag, with a strong earnings beat clouded by rising project costs.
Charting the best buy points for Amazon and Facebook, plus thoughts on Con Ed.
SO hasn't done anything wrong on the chart, but existing longs should reconsider their positions if the stock closes below $48.
Jim Cramer says in the utilities group, he's a fan of American Electric Power, which is owned by his charitable trust.
TheStreet's Jim Cramer says some biotech companies could be in play after the end of the deal between Pfizer and Allergan.
The market is no longer overestimating the potential for rate hikes; lock in utility profits now.